Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer.
breast
mastectomy
neoadjuvant therapy
radiotherapy
reconstructive surgical procedures
Journal
Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
19
07
2020
accepted:
08
03
2021
pubmed:
7
4
2021
medline:
29
10
2021
entrez:
6
4
2021
Statut:
ppublish
Résumé
Neoadjuvant radiotherapy (NART) as part of a multi-modality approach for locally advanced breast cancer (LABC) requires further investigation. Importantly, this approach may allow for a single-staged surgical procedure, with mastectomy and immediate autologous reconstruction. Multiple other potential benefits of NART include improved pathological downstaging of breast disease, reduced overall treatment time, elimination of time period with breast tissue deficit and improved patient satisfaction. This is a retrospective multi-institutional review of patients with LABC and high-risk breast disease undergoing NART. Eligible patients sequentially underwent neoadjuvant chemotherapy (NACT) with or without HER2-targeted therapy, NART, followed by mastectomy with immediate autologous breast reconstruction (BR) 4- to 6 weeks post-completion of radiotherapy. Patient and tumour characteristics were analysed using descriptive statistics. Surgical complications were assessed using the Clavien-Dindo Classification (Ann Surg 2004; 240: 205). From 3/2013 to 9/2019, 153 patients were treated with NART. The median age was 47 years (IQR 42-52), with median body mass index of 27. Eighteen patients experienced Grade 3 acute surgical complications. This included 13 Grade 3B breast-site events and 9 Grade 3B donor-site events, where further surgical intervention was required for management of wound infection, wound dehiscence, flap or mastectomy skin necrosis, haematoma and internal mammary venous anastomotic thrombosis. No autologous flap loss was observed. Neoadjuvant radiotherapy facilitates a single-stage surgical procedure with mastectomy and immediate autologous BR, eliminating the delay to reconstructive surgery and thus shortening a woman's breast cancer journey. The findings of this review support the use of NART, with comparable rates of surgical complications to standard sequencing.
Identifiants
pubmed: 33821576
doi: 10.1111/1754-9485.13180
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-353Informations de copyright
© 2021 The Royal Australian and New Zealand College of Radiologists.
Références
Australian Institute of Health and Welfare. Cancer in Australia 2019 Report. March 2019. DOI: https://doi.org/10.25816/5ebcc7a7fa7e9. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2019/data [Accessed 28th May, 2020].
Formenti SC, Volm M, Skinner KA et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a Phase I/II trial. Journal of Clin Oncol 2003; 21: 864-70.
American Joint Committee on Cancer. Cancer staging manual: breast chapter for 8th edition. Amin MB, Edge SB, Greene FL, et al. (editors). https://cancerstaging.org/references-tools/deskreferences/Pages/Breast-Cancer-Staging.aspx. [Accessed June 3rd, 2020].
Rogers N, Allen R. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg 2002; 109: 1919-24.
Tran NV, Chang DW, Gupta A et al. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2001; 108: 78-82.
Albino F, Patel K, Smith J, Nahabedian M. Delayed versus delayed-immediate autologous breast reconstruction: a blinded evaluation of aesthetic outcomes. Arch Plast Surg 2014; 41: 264-70.
Lentz R, Craig E, Higgins S, Salomon J, Fusi S. Breast reconstruction outcome study following radiation therapy - Autologous DIEP (Deep Inferior Epigastric Perforator) flap versus tissue expander. Eur J Surg Oncol 2012; 38: 875.
Billig J, Jagsi R, Hamill J, et al. Should immediate autologous breast reconstruction be considered in women who require postmastectomy radiation therapy? A prospective analysis of outcomes. Plast Reconstr Surg 2017; 139: 1279-1288.
Gerlach B, Audretsch W, Gogolin F et al. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy. Strahlenther. Onkol. 2003; 179: 306-11.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 pts and the results of a survey. Ann Surg 2004; 240: 205-13.
Ogston KN, Miller ID, Payne S et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003; 12: 320-7.
Monrigal E, Dauplat J, Gimbergues P et al. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study. Eur J Surg Oncol 2011; 37: 864-70.
Grinsell D, Pitcher M, Wong S, Guerrieri M, Nielson H. Immediate autologous breast reconstruction after neoadjuvant chemoradiotherapy for breast cancer: initial results of the first 29 patients. ANZ J Surg 2017; 88: 137-41.
Singh P, Hoffman K, Schaverien MV et al. Neoadjuvant radiotherapy to facilitate immediate breast reconstruction: a systematic review and current clinical trials. Ann Surg Oncol 2019; 26: 3312-20.
O’Halloran N, McVeigh T, Martin J, Keane M, Lowery A, Kerin M. Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer. Irish J Med Sci 2019; 188: 75-83.
Whelan TJ, Julian J, Wright J et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 18: 1220-9.
Tansley P, Ramsey K, Wong S, Guerrieri M, Pitcher M, Grinsell D. New treatment sequence protocol to reconstruct locally advanced breast cancer. ANZ J Surg 2013; 83: 630-5.
Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat 2011; 127: 15-22.
Jagsi R, Jiang J, Momoh AO et al. Complications after mastectomy and immediate breast reconstruction for breast cancer. Ann Surg 2016; 263: 219-27.
Jagsi R, Momoh AO, Qi JI et al. Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction. J Natl Cancer Inst 2018; 110: 157-65.
Shumway D, Momoh A, Sabel M, Jagsi R. Integration of Breast Reconstruction and Postmastectomy Radiotherapy. J Clin Oncol 2020; 38: 2329-38.
Fisher E, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Pathobiology of preoperative chemotherapy. Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18. Cancer 2002; 95: 681-95. https://doi.org/10.1002/cncr.10741.
Rouzier R, Perou CM, Symmans WF et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Am Assoc Cancer Res 2005; 11: 5678-85.
Paillocher N, Florczak AS, Richard M et al. Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma. Eur J Surg Oncol 2016; 42: 949-55.
Poleszczuk J, Luddy K, Chen LU et al. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res 2017; 19: 75.
Masuda N, Lee S-J, Ohtani S et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 2017; 376: 2147-59.
von Minckwitz G, Huang C-S, Mano MS et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019; 380: 617-28.